Antogen, Inc.

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://antogen.com/

Last Round

Seed

Jun 9, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Antogen, Inc. is a life sciences company that provides immunopeptidomics services and develops tools and diagnostics for immune surveillance.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Clinical Trials, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Usage-Based SaaS

AI Layer

Infrastructure

Keywords

immunopeptidomicsfee for servicecontract research organizationCROtherapeutic discoverylife sciences toolsantigen discoverybiomarker developmentproteomics platformimmunotherapy developmentoncology researchHLA peptide analysisneoantigen validationAI in drug discoveryAI-native biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Antogen, Inc. Comps

Public and private peers based on sector, stage, and business model.

Antogen, Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Antogen, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jun 9, 2026

View all Funding Rounds

Antogen, Inc. Investors

Notable investors and investment history

Antogen, Inc. investors
Investor	Rounds
iGrow Venture Partners	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 9, 2026
Seed round led by iGrow Venture Partners.

View all signals

Antogen, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Antogen, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Antogen, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Year FoundedN/A

Last FundingJun 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.